Philadelphia, PA · Founded 2023 · Privately Held (backing)
Developer of biological and small-molecule treatments designed for metabolic disease management. Alveus Therapeutics is based in Philadelphia, PA and was founded in 2023. It was valued at $275 million at its early-stage round in Feb 2026, the last priced event on record. It has raised $202 million across 1 recorded round; the latest was a $56.9 million later-stage round in Dec 2025.
PMV mark · valuation
$275.2M
Oct 2026
Priced at
its early-stage round
Feb 2026
Total raised
$202.0M
Last round
Later Stage VC
Dec 2025
Team — not yet on record
No current team members for Alveus Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alveus Therapeutics with a free account
·The complete investor list: 13 names
·Watch Alveus Therapeutics: the Monday email on marks, rounds and moves
